BIO-RAD LABORATORIES, INC. Deferred Revenue
BIO-RAD LABORATORIES, INC. (BIO) had Deferred Revenue of $66.00 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2026-08-04
- 2026-06-30: Deferred Revenue $66.00M.
- 2026-03-31: Deferred Revenue $69.90M.
- 2025-12-31: Deferred Revenue $62.90M.
- 2025-09-30: Deferred Revenue $64.00M.
| Period end | Deferred Revenue |
|---|---|
| 2026-06-30 | $66.00M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $69.90M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $62.90M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $64.00M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $68.90M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $68.10M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $61.50M 10-K · filed 2026-02-13 |
| 2024-09-30 | $64.00M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $67.40M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $70.80M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $68.30M 10-K · filed 2025-02-14 |
| 2023-09-30 | $66.50M 10-Q · filed 2023-10-27 |
| 2023-06-30 | $71.70M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $75.30M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $71.90M 10-K · filed 2024-02-16 |
| 2022-09-30 | $76.60M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $79.90M 10-Q · filed 2022-07-29 |
| 2022-03-31 | $59.40M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $71.00M 10-K · filed 2023-02-17 |
| 2021-09-30 | $67.00M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $66.20M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $66.20M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $60.00M 10-K · filed 2022-02-11 |
| 2020-09-30 | $55.80M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $51.00M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $50.90M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $45.80M 10-K · filed 2021-02-16 |
| 2019-09-30 | $45.60M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $44.40M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $41.10M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $37.30M 10-K · filed 2020-03-02 |
| 2018-09-30 | $39.30M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $41.40M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $38.20M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $36.70M 10-K · filed 2019-04-01 |